- Inflammatory bowel disease and superior mesenteric artery thromboembolism
-
Nicolaides S, Vasudevan , Langenberg DV
- KMID: 2501375
- Intest Res.
- 2020 Jan;18(1):130-133.
- doi: 10.5217/ir.2019.00068
While patients with inflammatory bowel disease are known to be at increased risk of venous thromboembolism, the risk of arterial thrombosis is less well recognized. Here, we describe the case... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
-
Nicolaides S, Vasudevan A, Long T, van Langenberg D
- KMID: 2515475
- Intest Res.
- 2021 Apr;19(2):158-170.
- doi: 10.5217/ir.2020.00008
Smoking significantly increases the risk of developing and worsens Crohn’s disease (CD), yet protects against the development and reduces the severity of ulcerative colitis. It is less clear whether smoking... -
- CITED
-
- Close
- SHARE
-
- Close
- Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
-
Con D, Andrew B, Nicolaides S, van Langenberg DR, Vasudevan A
- KMID: 2525077
- Intest Res.
- 2022 Jan;20(1):101-113.
- doi: 10.5217/ir.2020.00146
Background/Aims: The residual risk of colectomy after infliximab salvage in steroid-refractory acute severe ulcerative colitis (ASUC) is required to inform the need for subsequent maintenance biologic therapy. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
